This trial is testing if the addition of immunotherapy to the usual treatment will lead to better results for patients with esophagus or gastroesophagus cancer
Valerie Guild was Founder and President of the non-profit organization AIM at Melanoma, and served as a patient advocate on ECOG-ACRIN’s Melanoma Committee for over ten years.